• OPEN AN ACCOUNT
Indian Indices
Sensex
81,028.02 1,718.01
( 2.17%)
Global Indices
Nasdaq
51,462.04 -82.02
(-0.16%)
Dow Jones
7,424.83 50.10
(0.68%)
Hang Seng
57,293.47 -3,784.43
(-6.20%)
Nikkei 225
10,662.59 -120.07
(-1.11%)
Forex
USD-INR
94.41 -0.18
(-0.19%)
EUR-INR
106.07 -0.23
(-0.22%)
GBP-INR
127.18 -0.23
(-0.18%)
JPY-INR
0.60 0.00
(-0.04%)

EQUITY - MARKET SCREENER

Industry :  
BSE Code
ISIN Demat
Book Value()
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
EPS(TTM)
Face Value()
Div & Yield %
 

Indo US Bio-Tech standalone net profit declines 35.32% in the June 2026 quarter
Aug 12,2026
Net profit of Indo US Bio-Tech declined 35.32% to Rs 3.04 crore in the quarter ended June 2026 as against Rs 4.70 crore during the previous quarter ended June 2025. Sales rose 7.21% to Rs 32.99 crore in the quarter ended June 2026 as against Rs 30.77 crore during the previous quarter ended June 2025.

ParticularsQuarter Ended
Jun. 2026Jun. 2025% Var.
Sales32.9930.77 7
OPM %12.0317.78 -
PBDT3.355.02 -33
PBT3.084.82 -36
NP3.044.70 -35